These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2500307)

  • 21. Nasal mucociliary transport and ciliary ultrastructure in cystic fibrosis. A comparative study with healthy volunteers.
    Armengot M; Escribano A; Carda C; Sánchez C; Romero C; Basterra J
    Int J Pediatr Otorhinolaryngol; 1997 May; 40(1):27-34. PubMed ID: 9184975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How mutant CFTR may contribute to Pseudomonas aeruginosa infection in cystic fibrosis.
    Pier GB; Grout M; Zaidi TS; Goldberg JB
    Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 2):S175-82. PubMed ID: 8876538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa.
    Klepac-Ceraj V; Lemon KP; Martin TR; Allgaier M; Kembel SW; Knapp AA; Lory S; Brodie EL; Lynch SV; Bohannan BJ; Green JL; Maurer BA; Kolter R
    Environ Microbiol; 2010 May; 12(5):1293-303. PubMed ID: 20192960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Respiratory infection in cystic fibrosis: burden of illness in the progression of cystic fibrosis, previous deductions for the microbiological study of bronchial secretions and clinical criteria of infection].
    Thumerelle C
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S37-48. PubMed ID: 12910133
    [No Abstract]   [Full Text] [Related]  

  • 25. The approach to Pseudomonas aeruginosa in cystic fibrosis.
    Bendiak GN; Ratjen F
    Semin Respir Crit Care Med; 2009 Oct; 30(5):587-95. PubMed ID: 19760546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary infection in cystic fibrosis--still a sticky problem.
    Lancet; 1986 Dec; 2(8520):1372-3. PubMed ID: 2878232
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cystic fibrosis; current therapy. Infections].
    Schaad UB
    Schweiz Med Wochenschr Suppl; 2000; 122():22S-23S. PubMed ID: 12536466
    [No Abstract]   [Full Text] [Related]  

  • 28. Pseudomonas aeruginosa and cystic fibrosis: unusual bacterial adaptation and pathogenesis.
    Govan JR; Harris GS
    Microbiol Sci; 1986 Oct; 3(10):302-8. PubMed ID: 3155268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cystic fibrosis: intravenous treatment at home.
    Catchpole A
    Nurs Times; 1989 Mar 22-28; 85(12):40-2. PubMed ID: 2717454
    [No Abstract]   [Full Text] [Related]  

  • 30. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cystic fibrosis respiratory infections: interactions between bacteria and host defence.
    Döring G
    Monaldi Arch Chest Dis; 1997 Aug; 52(4):363-6. PubMed ID: 9401367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhaled liposomal amikacin.
    Waters V; Ratjen F
    Expert Rev Respir Med; 2014 Aug; 8(4):401-9. PubMed ID: 24882271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pseudomonas aeruginosa exoenzyme S as a pathogenic determinant in respiratory infections.
    Woods DE; To M; Sokol PA
    Antibiot Chemother (1971); 1989; 42():27-35. PubMed ID: 2512841
    [No Abstract]   [Full Text] [Related]  

  • 34. Pseudomonas infections in cystic fibrosis.
    George RH
    Arch Dis Child; 1987 May; 62(5):438-9. PubMed ID: 3111389
    [No Abstract]   [Full Text] [Related]  

  • 35. [Inhaled antibiotic therapy in cystic fibrosis].
    Girón Moreno RM; Salcedo Posadas A; Mar Gómez-Punter R
    Arch Bronconeumol; 2011 Jun; 47 Suppl 6():14-8. PubMed ID: 21703474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunology of Pseudomonas aeruginosa infection in cystic fibrosis.
    Høiby N; Pedersen SS; Jensen ET; Pressler T; Shand GH; Kharazmi A; Döring G
    Acta Univ Carol Med (Praha); 1990; 36(1-4):16-21. PubMed ID: 2130683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failure of local defense mechanisms in cystic fibrosis.
    Proesmans M; De Boeck K
    Acta Otorhinolaryngol Belg; 2000; 54(3):367-72. PubMed ID: 11082773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of multiresistant Pseudomonas aeruginosa infection in cystic fibrosis: how to progress?].
    Burgel PR; Kanaan R
    Rev Mal Respir; 2010 May; 27(5):411-3. PubMed ID: 20569871
    [No Abstract]   [Full Text] [Related]  

  • 39. [How should initial colonization by Pseudomonas aeruginosa be treated in patients with cystic fibrosis?].
    David V
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S113-7. PubMed ID: 12910143
    [No Abstract]   [Full Text] [Related]  

  • 40. Interaction between Pseudomonas aeruginosa and host defenses in cystic fibrosis.
    Marshall BC; Carroll KC
    Semin Respir Infect; 1991 Mar; 6(1):11-8. PubMed ID: 1909452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.